OptimizeRx Corporation (OPRX)

OptimizeRx Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	78.21	71.52	62.45	61.29	43.31	24.6
Revenue Growth (YoY)	26.71%	14.53%	1.89%	41.51%	76.08%	15.99%
Cost of Revenue	30.54	28.62	23.48	25.65	19.21	9.16
Gross Profit	47.67	42.9	38.97	35.64	24.11	15.44
Selling, General & Admin	63.16	60.42	51.26	35.28	26.24	19.13
Other Operating Expenses	8.88	8.88	0	0	0	0
Operating Expenses	72.04	69.3	51.26	35.28	26.24	19.13
Operating Income	-24.37	-26.4	-12.29	0.36	-2.14	-3.69
Interest Expense / Income	3	1.45	0	0	0	0
Other Expense / Income	-2.05	-2.69	-0.85	-0.02	0.07	0.35
Pretax Income	-25.32	-25.16	-11.44	0.38	-2.21	-4.04
Income Tax	-7.25	-7.6	0	0	0	-0.9
Net Income	-18.07	-17.57	-11.44	0.38	-2.21	-3.14
Shares Outstanding (Basic)	18	17	18	17	15	13
Shares Outstanding (Diluted)	18	17	18	18	15	13
Shares Change	6.29%	-3.71%	0.53%	19.31%	10.76%	12.85%
EPS (Basic)	-1.03	-1.03	-0.64	0.02	-0.15	-0.23
EPS (Diluted)	-1.03	-1.03	-0.64	0.02	-0.15	-0.23
Free Cash Flow	-5.83	-8.1	10.41	0.26	-6.42	-1.75
Free Cash Flow Per Share	-0.32	-0.47	0.58	0.01	-0.43	-0.13
Gross Margin	60.95%	59.98%	62.40%	58.14%	55.65%	62.77%
Operating Margin	-31.16%	-36.91%	-19.68%	0.59%	-4.93%	-15.02%
Profit Margin	-23.10%	-24.56%	-18.32%	0.62%	-5.10%	-12.78%
Free Cash Flow Margin	-7.45%	-11.33%	16.67%	0.43%	-14.83%	-7.11%
EBITDA	-19.32	-21.31	-9.42	2.34	-0.13	-2.76
EBITDA Margin	-24.70%	-29.79%	-15.08%	3.82%	-0.30%	-11.21%
Depreciation & Amortization	3	2.4	2.02	1.97	2.08	1.28
EBIT	-22.32	-23.71	-11.44	0.38	-2.21	-4.04
EBIT Margin	-28.54%	-33.15%	-18.32%	0.62%	-5.10%	-16.43%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).